Exotic Animal Importation, Sale, and Distribution Discussions; Notice of Public Meeting, 20402-20403 [E6-5926]
Download as PDF
<![CDATA[
20402
Federal Register / Vol. 71, No. 76 / Thursday, April 20, 2006 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel: Establishing a
Surveillance System for Chronic
Kidney Disease in the U.S., Program
Announcement PEP 2006–R–08
Correction: This notice was published
in the Federal Register on April 10,
2006, Volume 71, Number 68, page
18102. The matters to be discussed
during the Special Emphasis Panel
meeting have been changed.
Matters to be Discussed: To conduct
an expert review of the scientific and
technical merit of research proposals in
response to the development of a
comprehensive national kidney disease
surveillance system that will capture
and track all manifestations of Chronic
Kidney Disease in the general
population.
FOR FURTHER INFORMATION CONTACT:
Felix Rogers, PhD, M.P.H., Scientific
Review Administrator, CDC, 1600
Clifton Road, NE., Mailstop E–05,
Atlanta, GA 30333, Telephone Number
404.639.6101, e-mail fxr3@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: April 14, 2006.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E6–5928 Filed 4–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Exotic Animal Importation, Sale, and
Distribution Discussions; Notice of
Public Meeting
Centers for Disease Control and
Prevention, Department of Health and
Human Services.
ACTION: Notice of public meeting.
hsrobinson on PROD1PC61 with NOTICES
AGENCY:
This notice announces a
public meeting on the subject of the
importation, sale, and distribution of
exotic animals. The purpose of the
SUMMARY:
VerDate Aug<31>2005
14:56 Apr 19, 2006
Jkt 208001
meeting is to gather information and
discuss issues and concerns related to
infectious disease threats associated
with the importation, sale, and
distribution of exotic animals.
DATES: The public meeting will be held
May 18, 2006, from 1 p.m. to 5 p.m. in
Decatur, Georgia. Registration will begin
at 12 p.m.
ADDRESSES: The public meeting will be
held at the following location: Holiday
Inn Decatur Conference Plaza, 130
Clairemont Ave., Decatur, GA 30030.
Persons who are unable to attend the
meeting may e-mail, fax, or mail their
comments to: Attn: Kelly Crossett,
kcrossett@constellagroup.com; fax 919–
544–7507; Constella Group LLC, 2605
Meridian Parkway, Durham, NC 27713;
Written comments regarding the subject
of this meeting that are received by May
18, 2006 will receive the same
consideration as statements made at the
public meeting.
FOR FURTHER INFORMATION CONTACT:
Attn: Kelly Crossett, telephone 919–
313–7615;
kcrossett@constellagroup.com; fax 919–
544–7507; Constella Group LLC, 2605
Meridian Parkway, Durham, NC 27713.
SUPPLEMENTARY INFORMATION:
Participation at the Public Meeting
Submit requests to present a
statement at the public meeting to the
contact listed in the section titled FOR
FURTHER INFORMATION CONTACT. The CDC
should receive your requests to present
oral statements at the public meeting no
later than 10 days prior to the meeting.
Include a written summary of oral
remarks you would like to present and
the estimated time needed for your
presentation. A maximum of 15 minutes
per speaker will be permitted. Requests
received after the date specified above
will be scheduled during the meeting if
time allows; however, the names of
those individuals may not appear on the
written agenda. The CDC will prepare
an agenda of speakers available at the
meeting. To accommodate as many
speakers as possible, the amount of time
allocated to each speaker may be less
than the estimated 15 minute maximum.
Those persons desiring to have
audiovisual equipment available should
notify the CDC when they request
placement on the agenda. All statements
submitted during the meeting will be
considered part of the public record.
Background
Zoonoses are diseases that can be
transmitted from animals to people, and
prevention of zoonoses in humans poses
special challenges and requires
consideration of the role of exotic
PO 00000
Frm 00021
Fmt 4703
Sfmt 4703
animals in disease transmission. Wild
exotic animals may carry a variety of
known and emerging zoonotic
pathogens. The 2003 outbreak of
monkeypox in the United States, which
involved 37 confirmed human cases,
ultimately traced back to the
importation of African rodents, and
illustrates the special risk associated
with keeping wild animals as pets.
CDC’s regulations regarding the
importation of African rodents may be
found at 42 CFR 71.56. In addition, CDC
has issued orders prohibiting the
introduction into the United States of
birds from countries where highly
pathogenic avian influenza H5N1
subtype is present and civets. These
actions were taken to prevent the
introduction of monkeypox, avian
influenza, and SARS-coronavirus into
the United States. However, these
actions may not fully protect the general
public against the entry of zoonotic
diseases because they are limited to
specific species.
The American Veterinary Medical
Association (AVMA), the Council of
State and Territorial Epidemiologists
(CSTE), and the National Association of
State Public Health Veterinarians
(NASPHV) have issued position
statements calling for CDC to coordinate
a meeting to address the issue of
infectious disease risks associated with
the importation of exotic animals. This
meeting will invite discussion from
several federal agencies with regulatory
oversight of animals, interested
stakeholders (including AVMA, CSTE,
and NASPHV), and the general public
regarding infectious disease threats
related to exotic animal importation,
sale, and distribution. The public
meeting will be used as a forum to share
information, answer questions, and
discuss potential solutions concerning
infectious disease risks associated with
exotic animal importation, sale, and
distribution.
Public Meeting Procedures
The following procedures for this
meeting are as follows:
1. Admission and participation in the
public meeting are free. The meeting
will be open to all persons who have
requested in advance to present
statements or who register on the day of
the meeting (between 12 p.m. and 1
p.m.).
2. Representatives from the CDC will
conduct the public meeting. A panel of
Federal personnel and representatives
from veterinary and public health
organizations will discuss information
presented by participants.
3. The public meeting is intended as
a forum to share information and
E:\FR\FM\20APN1.SGM
20APN1
hsrobinson on PROD1PC61 with NOTICES
Federal Register / Vol. 71, No. 76 / Thursday, April 20, 2006 / Notices
answer questions concerning infectious
disease risks associated with the
importation, sale, and distribution of
exotic animals. Participants must limit
their presentations to the issue of exotic
animal importation, sale, and
distribution.
4. All interested parties will have the
opportunity to present any information
on the topic they want to be available
to CDC and other Federal partners. The
CDC and other federal partners will then
have the opportunity to explain the
methodology and technical assumptions
supporting its current observations.
5. Federal staff, representatives from
public health and veterinary
organizations, and public participants
may engage in a full discussion of all
technical material presented at the
meeting. Anyone presenting
conclusions will be expected to submit
their supporting data to the CDC.
6. The CDC will try to accommodate
all speakers. A maximum of 15 minutes
will be allowed for each speaker. Time
may be additionally limited for each
presentation, depending on the number
of speakers.
7. Sign interpretations will be made
available at the meeting, including
assistive listening devices, if requested
15 calendar days before the meeting.
8. Proceedings of the meeting will be
recorded and a summary will be posted
in the Federal Register.
9. The CDC will review and consider
all material presented by participants at
the public meeting. Position papers or
material presenting views or
information related to the subject of the
meeting may be accepted. The CDC
requests that persons participating in
the meeting provide 10 copies of all
materials to be presented for
distribution to the panel members; other
copies may be provided to the audience
at the discretion of the participant.
10. Statements made by CDC
personnel and other federal personnel
are intended to facilitate discussion of
the issues or to clarify issues. Such
statements should not be interpreted as
providing legal, professional, or other
advice.
11. The meeting is designed to share
information and solicit individual views
from the public and additional
information. The meeting will not
operate in consensus fashion. The
meeting will be conducted in an
informal and non-adversarial manner.
All statements submitted during the
meeting will be considered part of the
public record.
VerDate Aug<31>2005
14:56 Apr 19, 2006
Jkt 208001
Dated: April 12, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease
Control and Prevention.
[FR Doc. E6–5926 Filed 4–19–06; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 71 FR 6777, dated
February 9, 2006) is amended to reflect
the title change for the Division of
Policy Analysis and Coordination,
Office of Enterprise Communication,
Office of the Director, Centers for
Disease Control and Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete in its entirety the title for the
Division of Policy Analysis and
Coordination (CAUB) and insert the
Division of Issues Management and
Executive Secretariat (CAUB).
Dated: April 4, 2006.
William H. Gimson,
Chief Operating Officer, Centers for Disease
Control and Prevention (CDC).
[FR Doc. 06–3749 Filed 4–19–06; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Family Violence Prevention and
Services/Grants for Battered Women’s
Shelters/Grants to Native American
Tribes (Including Alaska Native
Villages) and Tribal Organizations
Program Office: Administration on
Children, Youth, and Families (ACYF),
Family and Youth Services Bureau
(FYSB).
Program Announcement Number:
HHS–2006–ACF–ACYF–FVPS–0124.
CFDA Number: 93.671.
Due Date for Applications: May 22,
2006.
PO 00000
Frm 00022
Fmt 4703
Sfmt 4703
20403
Executive Summary: This
announcement governs the proposed
award of formula grants under the
Family Violence Prevention and
Services Act (FVPSA) to Native
American Tribes (including Alaska
Native Villages) and Tribal
organizations. The purpose of these
grants is to assist Tribes in establishing,
maintaining, and expanding programs
and projects to prevent family violence
and to provide immediate shelter and
related assistance for victims of family
violence and their dependents.
This announcement sets forth the
application requirements, the
application process, and other
administrative and fiscal requirements
for grants in Fiscal Year (FY) 2006.
Grantees are to be mindful that although
the expenditure period for grants is a
two-year period, an application is
required every year to provide
continuity in the provision of services.
(See Section II. Award Information,
Expenditure Periods.)
I. Description
Legislative Authority: Title III of the
Child Abuse Amendments of 1984
(Public Law (Pub. L.) 98–457, 42 U.S.C.
10401 et seq.) is entitled the ‘‘Family
Violence Prevention and Services Act’’
(FVPSA). FVPSA was first implemented
in FY 1986. The statute was
subsequently amended by Public Law
100–294, the ‘‘Child Abuse Prevention,
Adoptions, and Family Services Act of
1988;’’ further amended in 1992 by
Public Law 102–295; and then amended
in 1994 by Public Law 103–322, the
‘‘Violent Crime Control and Law
Enforcement Act.’’ FVPSA was
amended again in 1996 by Public Law
104–235, the ‘‘Child Abuse Prevention
and Treatment Act (CAPTA) of 1996’’;
in 2000 by Public Law 106–386, the
‘‘Victims of Trafficking and Violence
Protection Act,’’ and amended further
by Public Law 108–36, the ‘‘Keeping
Children and Families Safe Act of
2003.’’ FVPSA was most recently
amended by Public Law 109–162, the
‘‘Violence Against Women and
Department of Justice Reauthorization
Act of 2005.’’
FVPSA may be found at 42 U.S.C.
10401 et seq.
Background
The purpose of this legislation is to
assist States and Tribes or Tribal
organizations in supporting the
establishment, maintenance, and
expansion of programs and projects to
prevent incidents of family violence and
to provide immediate shelter and
related assistance for victims of family
violence and their dependents.
E:\FR\FM\20APN1.SGM
20APN1
]]>Agencies
[Federal Register Volume 71, Number 76 (Thursday, April 20, 2006)]
[Notices]
[Pages 20402-20403]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-5926]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Exotic Animal Importation, Sale, and Distribution Discussions;
Notice of Public Meeting
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services.
ACTION: Notice of public meeting.
-----------------------------------------------------------------------
SUMMARY: This notice announces a public meeting on the subject of the
importation, sale, and distribution of exotic animals. The purpose of
the meeting is to gather information and discuss issues and concerns
related to infectious disease threats associated with the importation,
sale, and distribution of exotic animals.
DATES: The public meeting will be held May 18, 2006, from 1 p.m. to 5
p.m. in Decatur, Georgia. Registration will begin at 12 p.m.
ADDRESSES: The public meeting will be held at the following location:
Holiday Inn Decatur Conference Plaza, 130 Clairemont Ave., Decatur, GA
30030.
Persons who are unable to attend the meeting may e-mail, fax, or
mail their comments to: Attn: Kelly Crossett,
kcrossett@constellagroup.com; fax 919-544-7507; Constella Group LLC,
2605 Meridian Parkway, Durham, NC 27713; Written comments regarding the
subject of this meeting that are received by May 18, 2006 will receive
the same consideration as statements made at the public meeting.
FOR FURTHER INFORMATION CONTACT: Attn: Kelly Crossett, telephone 919-
313-7615; kcrossett@constellagroup.com; fax 919-544-7507; Constella
Group LLC, 2605 Meridian Parkway, Durham, NC 27713.
SUPPLEMENTARY INFORMATION:
Participation at the Public Meeting
Submit requests to present a statement at the public meeting to the
contact listed in the section titled FOR FURTHER INFORMATION CONTACT.
The CDC should receive your requests to present oral statements at the
public meeting no later than 10 days prior to the meeting. Include a
written summary of oral remarks you would like to present and the
estimated time needed for your presentation. A maximum of 15 minutes
per speaker will be permitted. Requests received after the date
specified above will be scheduled during the meeting if time allows;
however, the names of those individuals may not appear on the written
agenda. The CDC will prepare an agenda of speakers available at the
meeting. To accommodate as many speakers as possible, the amount of
time allocated to each speaker may be less than the estimated 15 minute
maximum. Those persons desiring to have audiovisual equipment available
should notify the CDC when they request placement on the agenda. All
statements submitted during the meeting will be considered part of the
public record.
Background
Zoonoses are diseases that can be transmitted from animals to
people, and prevention of zoonoses in humans poses special challenges
and requires consideration of the role of exotic animals in disease
transmission. Wild exotic animals may carry a variety of known and
emerging zoonotic pathogens. The 2003 outbreak of monkeypox in the
United States, which involved 37 confirmed human cases, ultimately
traced back to the importation of African rodents, and illustrates the
special risk associated with keeping wild animals as pets. CDC's
regulations regarding the importation of African rodents may be found
at 42 CFR 71.56. In addition, CDC has issued orders prohibiting the
introduction into the United States of birds from countries where
highly pathogenic avian influenza H5N1 subtype is present and civets.
These actions were taken to prevent the introduction of monkeypox,
avian influenza, and SARS-coronavirus into the United States. However,
these actions may not fully protect the general public against the
entry of zoonotic diseases because they are limited to specific
species.
The American Veterinary Medical Association (AVMA), the Council of
State and Territorial Epidemiologists (CSTE), and the National
Association of State Public Health Veterinarians (NASPHV) have issued
position statements calling for CDC to coordinate a meeting to address
the issue of infectious disease risks associated with the importation
of exotic animals. This meeting will invite discussion from several
federal agencies with regulatory oversight of animals, interested
stakeholders (including AVMA, CSTE, and NASPHV), and the general public
regarding infectious disease threats related to exotic animal
importation, sale, and distribution. The public meeting will be used as
a forum to share information, answer questions, and discuss potential
solutions concerning infectious disease risks associated with exotic
animal importation, sale, and distribution.
Public Meeting Procedures
The following procedures for this meeting are as follows:
1. Admission and participation in the public meeting are free. The
meeting will be open to all persons who have requested in advance to
present statements or who register on the day of the meeting (between
12 p.m. and 1 p.m.).
2. Representatives from the CDC will conduct the public meeting. A
panel of Federal personnel and representatives from veterinary and
public health organizations will discuss information presented by
participants.
3. The public meeting is intended as a forum to share information
and
[[Page 20403]]
answer questions concerning infectious disease risks associated with
the importation, sale, and distribution of exotic animals. Participants
must limit their presentations to the issue of exotic animal
importation, sale, and distribution.
4. All interested parties will have the opportunity to present any
information on the topic they want to be available to CDC and other
Federal partners. The CDC and other federal partners will then have the
opportunity to explain the methodology and technical assumptions
supporting its current observations.
5. Federal staff, representatives from public health and veterinary
organizations, and public participants may engage in a full discussion
of all technical material presented at the meeting. Anyone presenting
conclusions will be expected to submit their supporting data to the
CDC.
6. The CDC will try to accommodate all speakers. A maximum of 15
minutes will be allowed for each speaker. Time may be additionally
limited for each presentation, depending on the number of speakers.
7. Sign interpretations will be made available at the meeting,
including assistive listening devices, if requested 15 calendar days
before the meeting.
8. Proceedings of the meeting will be recorded and a summary will
be posted in the Federal Register.
9. The CDC will review and consider all material presented by
participants at the public meeting. Position papers or material
presenting views or information related to the subject of the meeting
may be accepted. The CDC requests that persons participating in the
meeting provide 10 copies of all materials to be presented for
distribution to the panel members; other copies may be provided to the
audience at the discretion of the participant.
10. Statements made by CDC personnel and other federal personnel
are intended to facilitate discussion of the issues or to clarify
issues. Such statements should not be interpreted as providing legal,
professional, or other advice.
11. The meeting is designed to share information and solicit
individual views from the public and additional information. The
meeting will not operate in consensus fashion. The meeting will be
conducted in an informal and non-adversarial manner. All statements
submitted during the meeting will be considered part of the public
record.
Dated: April 12, 2006.
James D. Seligman,
Chief Information Officer, Centers for Disease Control and Prevention.
[FR Doc. E6-5926 Filed 4-19-06; 8:45 am]
BILLING CODE 4163-18-P
